Nextcure Inc

Research Nextcure Inc (NXTC) on Bullrun: market cap USD 6.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNXTC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.31M
• Financial periodFY2025
• Net income-USD 55.84M

Valuation Snapshot

latest market cap is USD 6.31M.

About Nextcure Inc

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease;

Frequently asked questions

What is Nextcure Inc's market cap?

Nextcure Inc's market capitalization is USD 6.31M.

What does Nextcure Inc do?

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors.